{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:27:50Z","timestamp":1792931270100,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00228-016-2167-1","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T16:45:57Z","timestamp":1480178757000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma"],"prefix":"10.1007","volume":"73","author":[{"given":"Shinichi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,26]]},"reference":[{"issue":"5","key":"2167_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466. doi: 10.1016\/s1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"issue":"3","key":"2167_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11060-004-9175-1","volume":"70","author":"C Balana","year":"2004","unstructured":"Balana C, Lopez-Pousa A, Berrocal A et al (2004) Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish medical neuro-oncology group (GENOM). J Neuro-Oncol 70(3):359\u2013369","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"2167_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"CU Johannessen","year":"2003","unstructured":"Johannessen CU, Johannessen SI (2003) Valproate: past, present, and future. CNS drug reviews 9(2):199\u2013216","journal-title":"CNS drug reviews"},{"issue":"2","key":"2167_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"CL Harden","year":"2009","unstructured":"Harden CL, Meador KJ, Pennell PB et al (2009) Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73(2):133\u2013141. doi: 10.1212\/WNL.0b013e3181a6b312","journal-title":"Neurology"},{"issue":"5","key":"2167_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6(5):421\u2013430. doi: 10.1016\/s1474-4422(07)70103-5","journal-title":"Lancet Neurol"},{"issue":"39","key":"2167_CR6","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276(39):36734\u201336741. doi: 10.1074\/jbc.M101287200","journal-title":"J Biol Chem"},{"issue":"9","key":"2167_CR7","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1158\/0008-5472.can-04-2478","volume":"65","author":"DC Marchion","year":"2005","unstructured":"Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN (2005) Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 65(9):3815\u20133822. doi: 10.1158\/0008-5472.can-04-2478","journal-title":"Cancer Res"},{"issue":"15","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/jco.2006.08.6165","volume":"25","author":"P Munster","year":"2007","unstructured":"Munster P, Marchion D, Bicaku E et al (2007) Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. J Clin Oncol 25(15):1979\u20131985. doi: 10.1200\/jco.2006.08.6165","journal-title":"J Clin Oncol"},{"issue":"3","key":"2167_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","volume":"86","author":"CA Barker","year":"2013","unstructured":"Barker CA, Bishop AJ, Chang M, Beal K, Chan TA (2013) Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86(3):504\u2013509. doi: 10.1016\/j.ijrobp.2013.02.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2167_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross JG et al (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77(12):1156\u20131164. doi: 10.1212\/WNL.0b013e31822f02e1","journal-title":"Neurology"},{"issue":"3","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hed.21734","volume":"34","author":"CP Gan","year":"2012","unstructured":"Gan CP, Hamid S, Hor SY, Zain RB, Ismail SM, Wan Mustafa WM, Teo SH, Saunders N, Cheong SC (2012) Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence. Head Neck 34(3):344\u2013353. doi: 10.1002\/hed.21734","journal-title":"Head Neck"},{"issue":"4","key":"2167_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1667\/rr1245.1","volume":"169","author":"SL Brown","year":"2008","unstructured":"Brown SL, Kolozsvary A, Liu J, Ryu S, Kim JH (2008) Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. Radiat Res 169(4):474\u2013478. doi: 10.1667\/rr1245.1","journal-title":"Radiat Res"},{"issue":"1","key":"2167_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdermsci.2013.05.007","volume":"72","author":"SJ Jo","year":"2013","unstructured":"Jo SJ, Choi SJ, Yoon SY, Lee JY, Park WS, Park PJ, Kim KH, Eun HC, Kwon O (2013) Valproic acid promotes human hair growth in in vitro culture model. J Dermatol Sci 72(1):16\u201324. doi: 10.1016\/j.jdermsci.2013.05.007","journal-title":"J Dermatol Sci"},{"issue":"4","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"e34152","DOI":"10.1371\/journal.pone.0034152","volume":"7","author":"SH Lee","year":"2012","unstructured":"Lee SH, Yoon J, Shin SH et al (2012) Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. PLoS One 7(4):e34152. doi: 10.1371\/journal.pone.0034152","journal-title":"PLoS One"},{"issue":"4","key":"2167_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1346-8138.12422","volume":"41","author":"SJ Jo","year":"2014","unstructured":"Jo SJ, Shin H, Park YW, Paik SH, Park WS, Jeong YS, Shin HJ, Kwon O (2014) Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis. J Dermatol 41(4):285\u2013291. doi: 10.1111\/1346-8138.12422","journal-title":"J Dermatol"},{"issue":"26","key":"2167_CR16","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/092986707782360088","volume":"14","author":"MF Reynolds","year":"2007","unstructured":"Reynolds MF, Sisk EC, Rasgon NL (2007) Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Curr Med Chem 14(26):2799\u20132812","journal-title":"Curr Med Chem"},{"issue":"1\u20133","key":"2167_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","volume":"542","author":"MR Jeong","year":"2003","unstructured":"Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542(1\u20133):74\u201378","journal-title":"FEBS Lett"},{"issue":"47","key":"2167_CR18","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1073\/pnas.0407643101","volume":"101","author":"J Hsieh","year":"2004","unstructured":"Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 101(47):16659\u201316664. doi: 10.1073\/pnas.0407643101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5532","key":"2167_CR19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD (2001) Translating the histone code. Science 293(5532):1074\u20131080. doi: 10.1126\/science.1063127","journal-title":"Science"},{"issue":"16","key":"2167_CR20","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"G Rosenberg","year":"2007","unstructured":"Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64(16):2090\u20132103. doi: 10.1007\/s00018-007-7079-x","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.npp.1300283","volume":"29","author":"TD Gould","year":"2004","unstructured":"Gould TD, Chen G, Manji HK (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29(1):32\u201338. doi: 10.1038\/sj.npp.1300283","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2167_CR22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/mcne.2002.1117","volume":"20","author":"AC Hall","year":"2002","unstructured":"Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, Salinas PC (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20(2):257\u2013270","journal-title":"Mol Cell Neurosci"},{"key":"2167_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2121-9-66","volume":"9","author":"GA Jung","year":"2008","unstructured":"Jung GA, Yoon JY, Moon BS, Yang DH, Kim HY, Lee SH, Bryja V, Arenas E, Choi KY (2008) Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21 Cip\/WAF1 pathway. BMC Cell Biol 9:66. doi: 10.1186\/1471-2121-9-66","journal-title":"BMC Cell Biol"},{"issue":"6","key":"2167_CR24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1523-1747.2003.12568.x","volume":"121","author":"KJ McElwee","year":"2003","unstructured":"McElwee KJ, Kissling S, Wenzel E, Huth A, Hoffmann R (2003) Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla. J Invest Dermatol 121(6):1267\u20131275. doi: 10.1111\/j.1523-1747.2003.12568.x","journal-title":"J Invest Dermatol"},{"issue":"5804","key":"2167_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1126\/science.1130088","volume":"314","author":"S Sick","year":"2006","unstructured":"Sick S, Reinker S, Timmer J, Schlake T (2006) WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism. Science 314(5804):1447\u20131450. doi: 10.1126\/science.1130088","journal-title":"Science"},{"issue":"2","key":"2167_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.0022-202x.2001.01670.x","volume":"118","author":"SE Millar","year":"2002","unstructured":"Millar SE (2002) Molecular mechanisms regulating hair follicle development. J Invest Dermatol 118(2):216\u2013225. doi: 10.1046\/j.0022-202x.2001.01670.x","journal-title":"J Invest Dermatol"},{"issue":"5","key":"2167_CR27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1534-5807(02)00167-3","volume":"2","author":"T Andl","year":"2002","unstructured":"Andl T, Reddy ST, Gaddapara T, Millar SE (2002) WNT signals are required for the initiation of hair follicle development. Dev Cell 2(5):643\u2013653","journal-title":"Dev Cell"},{"issue":"10","key":"2167_CR28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1101\/gad.14.10.1181","volume":"14","author":"J Kishimoto","year":"2000","unstructured":"Kishimoto J, Burgeson RE, Morgan BA (2000) Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev 14(10):1181\u20131185","journal-title":"Genes Dev"},{"issue":"2","key":"2167_CR29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4773(01)00563-9","volume":"109","author":"M Ridanpaa","year":"2001","unstructured":"Ridanpaa M, Fodde R, Kielman M (2001) Dynamic expression and nuclear accumulation of beta-catenin during the development of hair follicle-derived structures. Mech Dev 109(2):173\u2013181","journal-title":"Mech Dev"},{"issue":"4","key":"2167_CR30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0092-8674(01)00336-1","volume":"105","author":"J Huelsken","year":"2001","unstructured":"Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105(4):533\u2013545","journal-title":"Cell"},{"issue":"13","key":"2167_CR31","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1158\/1078-0432.ccr-04-2088","volume":"11","author":"A Munshi","year":"2005","unstructured":"Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE (2005) Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11(13):4912\u20134922. doi: 10.1158\/1078-0432.ccr-04-2088","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2167_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","volume":"30","author":"S Bhaskara","year":"2008","unstructured":"Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, Hiebert SW (2008) Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell 30(1):61\u201372. doi: 10.1016\/j.molcel.2008.02.030","journal-title":"Mol Cell"},{"issue":"4","key":"2167_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11481-010-9192-0","volume":"5","author":"HS Suh","year":"2010","unstructured":"Suh HS, Choi S, Khattar P, Choi N, Lee SC (2010) Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J NeuroImmune Pharmacol 5(4):521\u2013532. doi: 10.1007\/s11481-010-9192-0","journal-title":"J NeuroImmune Pharmacol"},{"issue":"1","key":"2167_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2014.02.032","volume":"20","author":"U Jambalganiin","year":"2014","unstructured":"Jambalganiin U, Tsolmongyn B, Koide N, Odkhuu E, Naiki Y, Komatsu T, Yoshida T, Yokochi T (2014) A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid. Int Immunopharmacol 20(1):181\u2013187. doi: 10.1016\/j.intimp.2014.02.032","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2167_CR35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/cc.7.4.5405","volume":"7","author":"KN Harikrishnan","year":"2008","unstructured":"Harikrishnan KN, Karagiannis TC, Chow MZ, El-Osta A (2008) Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell Cycle 7(4):468\u2013476","journal-title":"Cell Cycle"},{"issue":"4","key":"2167_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/neuonc\/nop005","volume":"12","author":"J Fu","year":"2010","unstructured":"Fu J, Shao CJ, Chen FR, Ng HK, Chen ZP (2010) Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro-Oncology 12(4):328\u2013340. doi: 10.1093\/neuonc\/nop005","journal-title":"Neuro-Oncology"},{"issue":"1","key":"2167_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","volume":"107","author":"KA Van Nifterik","year":"2012","unstructured":"Van Nifterik KA, Van den Berg J, Slotman BJ, Lafleur MV, Sminia P, Stalpers LJ (2012) Valproic acid sensitizes human glioma cells for temozolomide and \u03b3-radiation. J Neuro-Oncol 107(1):61\u201367. doi: 10.1007\/s11060-011-0725-z","journal-title":"J Neuro-Oncol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2167-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:35:47Z","timestamp":1657845347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2167-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,26]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2167-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,26]]}}}